×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Addressing Participation Burden in Clinical Trials: Evidence, Participant Feedback, and Signal Interpretation to Drive Impact
Session Chair(s)
Lani Hashimoto
Consultant, Patient Experience
Hashimoto Consulting Services, United States
This session examines the relationship between protocol complexity, participant burden, and enrollment challenges, alongside the development and impact of participant feedback questionnaires. Patient advisors and attendees will interpret results and discuss improvements in trial performance.
Learning Objective : Assess patient participation burden based on protocol design characteristics and requirements; Identify design elements driving elevated levels of burden and impacting clinical trial performance; Manipulate results into practical improvements for clinical research projects; Express the value of participant feedback and compose rationale for inclusion of feedback in future studies; Develop strategies to reduce and address clinical trial and portfolio-wide participation burden.
Speaker(s)
Addressing Participation Burden in Clinical Trials: Primary Causes, Outcomes and Mitigation Strategies and Practices
Kenneth Getz, MBA
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Participant Feedback Forum: Active Interpretation of Signals by Patient Advisors and Attendees
Lani Hashimoto
Hashimoto Consulting Services, United States
Consultant, Patient Experience
Have an account?